Immunology & Cell Biology
The flagship journal of ASI, and one of the leading immunology journals, with a history of 90 years of innovative publishing.
2018 Impact Factor 3.947
2018 5-year Impact Factor 4.218
ICB spans the breadth of immunology with an emphasis on the cell biology of the immune system. Of particular interest are the areas of cellular immunology, innate and adaptive immunity, immune responses to pathogens, tumour immunology, immunopathology and immunogenetics.
ICB is the home to 90 publications by Burnet in developing his theories leading to the award of the Nobel Prize in Physiology in 1960.
IMMUNOLOGY & CELL BIOLOGY COVERS:
- Cellular immunology
- Immune responses to pathogens
- Innate and adaptive immunity
- Tumour immunology
- Immunological studies in humans and model organs (including mouse, rat, Drosophila, etc.)
FEATURES OF IMMUNOLOGY & CELL BIOLOGY
- Rapid evaluation for publication
- Average Time to First decision of 16 days
- Average Time to Print publication of 2.2 months
- 2017 Impact Factor 3.795
- Outstanding Observations – Rapid publication of cutting-edge research
- Original Articles, Reviews, Perspectives, New & Commentaries, Special Features
- Special Features
- Open Access Option – Direct to peers
- Member of COPE for responsible publication ethics
- Eligibility for the ICB Altmetric Award
ADDITIONAL BENEFITS FOR ASI MEMBERS
- When selecting the OnlineOpen option in ICB receive a 20% discount off the Article Publication Charge *
- Be in the running for the award of ‘ICB Publication of the Year’, which also includes a speakers slot at the ASI annual meeting**
*Eligible only to current financial ASI members. Visit the Member Login Section for the member-only code to apply.
**Awarded to the best publication from a current financial ASI member who is first author.
ICB celebrates Day of Immunology
The growth of mouse bone marrow cells in vitro. Bradley, T.R. & Metcalf, D. Aust J Exp Biol Med Sci 44, 287-299 (1966).
>2000 citations – a cornerstone publication allowing identification and characterisation of CSFs.
A reassessment of the forbidden clone hypothesis of autoimmune disease. Burnet, F.M. Aust J Exp Biol Med Sci 50, 1-9 (1972).